代谢组学
基因组
计算生物学
失调
生物
结直肠癌
微生物群
代谢途径
肠道菌群
代谢组
串扰
肠道微生物群
诊断生物标志物
生物信息学
微生物代谢
重编程
系统生物学
蛋白质组
小桶
猎枪
癌变
遗传学
转录组
脆弱类杆菌
通路分析
新陈代谢
化学
克拉斯
生物标志物
鸟枪蛋白质组学
蛋白质基因组学
癌症研究
霰弹枪测序
致病性
作者
Haifan Lin,Wenjing Wu,Huiqi Fang,Yiqun Chen,Hongying Wu,Xiaoxin Lai,Linlin Li
摘要
Colorectal cancer (CRC) arises via the stepwise adenoma-carcinoma sequence (ACS). Gut microbial dysbiosis and host metabolic reprogramming jointly correlate with CRC onset and advancement, yet their stage-specific crosstalk across ACS remains largely unclear. Limited multi-omics research on microbial-metabolic interactions throughout ACS hinders the development of early diagnostic biomarkers and preventive strategies. Here, we combined untargeted mucosal metabolomics and fecal shotgun metagenomic sequencing in 36 participants, covering healthy controls, ACS, and CRC patients. We systematically analyzed microbial composition, functions, differential metabolites, and enriched pathways and integrated multi-omics data to screen stage-specific signatures. Distinct gut microbial profiles and progressive functional shifts toward pathogenicity and abnormal carbohydrate metabolism were observed along ACS. Mucosal metabolism was continuously disrupted, with prominent alterations in taurine-hypotaurine, sphingolipid, and bile acid pathways. Core differential metabolites showed excellent diagnostic performance. Microbe-metabolite interactions were progressively enhanced to form a concerted pro-tumor axis. This study characterizes unique ACS-stage microbial-metabolic features. Dysregulated metabolic pathways and key microbe-metabolite crosstalk are closely associated with CRC progression, offering novel non-invasive biomarkers and premalignant intervention targets.
科研通智能强力驱动
Strongly Powered by AbleSci AI